Abstract
We developed a novel culture-based test, the Rapid CAZ/AVI NP test, for rapid identification of ceftazidime/ avibactam susceptibility/resistance in Enterobacterales. This test is based on glucose metabolization upon bacterial growth in the presence of a defined concentration of ceftazidime/avibactam (128/53 µg/mL). Bacterial growth is visually detectable by a red to yellow color change of red phenol, a pH indicator. A total of 101 well characterized enterobacterial isolates were used to evaluate the test performance. This test showed positive percent agreement of 100% and negative percent agreement of 98.5% with overall percent agreement of 99%, by comparison with the MIC gradient strip test (Etest) taken as the reference standard method. The Rapid CAZ/AVI NP test had only 1.5% major errors and 0% extremely major errors. This test is rapid (result within 2 hours 45 minutes), reliable, affordable, easily interpretable, and easy to implement in clinical microbiology laboratories without requiring any specific equipment.
Cite
CITATION STYLE
Nordmann, P., Bouvier, M., Delaval, A., Tinguely, C., Poirel, L., & Sadek, M. (2024). Rapid Detection of Ceftazidime/ Avibactam Susceptibility/ Resistance in Enterobacterales by Rapid CAZ/AVI NP Test. Emerging Infectious Diseases, 30(2), 255–261. https://doi.org/10.3201/eid3002.221398
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.